1 How this is
accomplished is controversial.
2 ement of subsets of clinical T1N0 esophageal
adenocarcinoma is controversial.
3 ure, and the underlying mechanism of wettability
alteration is controversial.
4 result, the appropriate time to monitor patients after
ASA is controversial.
5 al antibiotic regimen for Pseudomonas aeruginosa
bacteremia is controversial.
6 Expression of PD-1 on NK
cells is controversial despite rapid incorporation into clinical ca
7 eal intubation attempt and intubation-related
complications is controversial.
8 ined within EVs or is instead an extravesicular
contaminant is controversial.
9 The role of neuroleptics for terminal agitated
delirium is controversial.
10 mpact of hormonal contraceptives on the risk for
depression is controversial; however, clinical studies and randomized pl
11 The optimal macronutrient composition of the
diet is controversial and many adults attempt to regulate the inta
12 ogenic or protective role during inflammatory bowel
disease is controversial.
13 ization improves prognosis in stable ischemic heart
disease is controversial.
14 in the development of oral tolerance and allergic
diseases is controversial, which could be related to variability in mi
15 virus (HIV) infection impacts gut microbial alpha-
diversity is controversial.
16 of their specific exposure and complex immune
dysregulation is controversial.
17 ic treatment with bevacizumab in patients with
glioblastoma is controversial because progression-free survival benefit di
18 role of keratinized mucosa in promoting peri-implant
health is controversial, however recent evidence support the use of
19 The presence of active neurogenic niches in adult
humans is controversial.
20 n as "hidden hearing loss," but support for this
hypothesis is controversial.
21 pulmonary disease (COPD) with inhaled corticosteroids (
ICS)
is controversial, because it can reduce the risk of future ex
22 other functions pDCs exert in vivo during viral
infections is controversial, and more studies are needed to understand t
23 vent pulmonary hypertension after intrauterine
inflammation is controversial.Objectives: To determine whether antenatal o
24 The evolutionary significance of epigenetic
inheritance is controversial.
25 regulation through RAS and the sufficiency of those
inputs is controversial or unclear.
26 However, the clinical relevance of this
interaction is controversial.
27 s, although the effectiveness of many medical
interventions is controversial.
28 It is controversial whether blister formation is due to direct i
29 It is controversial whether the phosphate (Pi) release step in t
30 HNF1alpha in pancreatic ductal adenocarcinoma (PDAC) but
it is controversial.
31 However,
it is controversial whether BCO2 function is conserved in humans
32 earing is degenerate or adaptive to their unique
lifestyles is controversial.
33 But this
method is controversial because it requires the assistance of anothe
34 test susceptible, the value of piperacillin-tazobactam
MICs is controversial.
35 channel localizes to vascular endothelium or smooth
muscle is controversial and the distribution and functional roles of
36 e of aromatase inhibitors (AIs) and cardiovascular
outcomes is controversial.
37 In particular, whether microglia become
phagocytic is controversial.
38 However, the function of
phosphorylation is controversial and the mechanism of anti-adaptors preventin
39 ain, its molecular binding activity towards RNA and
protein is controversial.
40 chymal-to-endothelial transition in the angiogenic
response is controversial.
41 1) clearly being involved in sterile inflammation, its
role is controversial because of a paucity of patient-focused rese
42 ing chronic obstructive pulmonary disease risk and
severity is controversial.Objectives: To comprehensively evaluate the
43 precise prevalence of new-onset or worsening GERD after
SG is controversial.
44 parum variant surface proteins, such as RIFINs and
STEVORs,
is controversial.
45 promote actin assembly, but the mechanism of their
synergy is controversial.
46 ce the risk of atopic dermatitis (AD) in children, but
this is controversial and US data are limited.
47 tive evidence-based interventions, but the use of
tocolysis is controversial.
48 id, but whether or not they help people to quit tobacco
use is controversial.
49 ective, the specificity and mechanism of the inhibitor
used is controversial.
50 ral density (BMD) and periodontitis in perimenopausal
women is controversial.